{"settlement":{"id":"valeant-opioid-settlement-2026","slug":"valeant-opioid-settlement-2026","title":"Valeant and Bausch Health Settlement","category":"Pharmaceutical and Medical Devices","status":"Claims not yet open","tags":{"industry":["Pharmaceutical and medical devices"],"geographic":["Canada-wide (Except Quebec)"],"recoveryType":["Cash payment"],"documentation":["To be determined"],"eligibilityTrigger":["Was a patient or received treatment"]},"classDefinition":"All persons in Canada (except Quebec) who were prescribed or consumed any opioid product (as defined in the Settlement Agreement), together with their heirs, and any member of the Family Law Class. The Family Law Class includes persons who, by reason of a relationship to a Class Member, have standing under section 61(1) of the Family Law Act or equivalent legislation.","plainLanguageSummary":"If you were prescribed or consumed opioid products in Canada (outside Quebec) since January 1, 1996, or you are a family member of someone who was, you may be eligible for a share of a proposed $600,000 settlement with Valeant if the court approves it.","eligibilityCriteria":[],"recoveryRange":"Share of a $600,000 settlement fund, distribution plan to be approved later","filingInstructions":"","caseBackground":"A national class action claims that major pharmaceutical companies promoted opioid medications for chronic conditions starting in the 1990s, leading to widespread addiction among people who were prescribed them. The lawsuit also says the companies failed to warn about the dangers of these drugs. Valeant Canada and Bausch Health Companies, which sold opioid products in Canada such as M.O.S. (Morphine Hydrochloride) products, Cophylac, Onsolis, Opana ER, Painex, Kadian and Ralivia, have agreed to a proposed settlement of $600,000 to end the claims against them. Valeant denies the allegations, and no court has found it liable.\n\nThe settlement must be approved by the Ontario Superior Court of Justice before it becomes final. A settlement approval hearing is scheduled for September 16, 2026 in Toronto. The lawsuit continues against the other pharmaceutical companies that have not settled, and lawyers for the class plan to ask the court later in 2026 to approve a plan for distributing the settlement money to class members. Details on how to make a claim will be announced after that.","administratorName":"","administratorContacts":[],"administratorRole":"claims","agentName":null,"agentContacts":[],"agentClaimFormHelp":false,"classCounselName":"Koskie Minsky LLP","classCounselContacts":[{"type":"phone","label":"","value":"1-833-630-1776"},{"type":"email","label":"","value":"opioidclassaction@kmlaw.ca"},{"type":"mail","label":"","value":"Koskie Minsky LLP, 20 Queen Street West, Suite 900, Toronto, ON, M5H 3R3"},{"type":"online","label":"","value":"https://kmlaw.ca/cases/liability-for-opioid-epidemic/"}],"classCounselFirms":[{"name":"Koskie Minsky LLP","region":"","contacts":[{"type":"phone","label":"","value":"1-833-630-1776"},{"type":"email","label":"","value":"opioidclassaction@kmlaw.ca"},{"type":"mail","label":"","value":"Koskie Minsky LLP, 20 Queen Street West, Suite 900, Toronto, ON, M5H 3R3"},{"type":"online","label":"","value":"https://kmlaw.ca/cases/liability-for-opioid-epidemic/"}]}],"submissionMethods":[],"sourceDocuments":[{"url":"/uploads/1aa5f348b9bfcdecfcd11d7f-Long_Form_Notice_of_Certification_and_Settlement_Approval_Hearing_Valeant.pdf","title":"Notice to Class Members"},{"url":"/uploads/a873b44bedd53cc993035e52-Long_Form_Notice_of_Certification_and_Settlement_Approval_Hearing_Valeant_FR.pdf","title":"Avis aux membres du groupe"}],"shortFormNoticeUrl":"/uploads/36d8dff92ac0fd1b5748554a-Short_Form_Notice_of_Certification_and_Settlement_Approval_Hearing_Valeant.pdf","longFormNoticeUrl":"/uploads/1aa5f348b9bfcdecfcd11d7f-Long_Form_Notice_of_Certification_and_Settlement_Approval_Hearing_Valeant.pdf","settlementAgreementUrl":"","claimFormDocumentUrl":"","claimForms":[],"claimFormsButtonLabel":"claim-form","claimFormsUnavailable":false,"claimFormsUnavailableReason":null,"claimFormGuides":[],"additionalDocuments":[],"optOutFormUrl":"","optOutInstructions":"To opt out, you must complete an Opt Out Form and email it or mail it (postmarked) to Class Counsel by May 4, 2026, at opioidclassaction@kmlaw.ca or Koskie Minsky LLP, 20 Queen Street West, Suite 900, Toronto, ON, M5H 3R3, Re: Opioids Class Action. You cannot opt out by phone or through the website. That deadline has now passed.","objectionFormUrl":null,"objectionInstructions":null,"faqs":[{"answer":"Valeant Canada and Bausch Health Companies have agreed to pay an all-inclusive $600,000 CAD to end the class action against them. The lawsuit continues against the other pharmaceutical companies that have not settled.","question":"What is the proposed settlement?"},{"answer":"Not yet. The settlement must first be approved by the court at a hearing scheduled for September 16, 2026. Class Counsel then intends to ask the court later in 2026 to approve a plan for distributing the settlement money, and will give notice of how to make a claim.","question":"When will I be able to make a claim?"},{"answer":"If you support the proposed settlement, you do not need to do anything. To receive future notices about the settlement, register by emailing opioidclassaction@kmlaw.ca.","question":"What do I need to do right now?"},{"answer":"No. The deadline to submit an Objection Form or an Opt Out Form to Class Counsel was May 4, 2026, and it has passed.","question":"Can I still object to the settlement or opt out?"},{"answer":"No. Class members are not charged for the services of Class Counsel. Class Counsel will ask the court to approve a fee of 25% of the settlement funds at the approval hearing, and the court will decide whether that is fair.","question":"Will I have to pay legal fees?"}],"eligibilityChecker":{"questions":[{"id":"prescribed-or-consumed-opioids","text":"Were you prescribed or did you consume any opioid product in Canada since January 1, 1996, or are you an heir or family member of someone who was?","type":"yes_no","helpText":"Opioid products include drugs such as morphine, codeine, fentanyl, oxycodone, hydromorphone, methadone and tramadol.","qualifyingAnswer":"yes","criticalForEligibility":true},{"id":"outside-quebec","text":"Do you live in Canada outside of Quebec?","type":"yes_no","helpText":"The settlement class covers people in Canada except Quebec.","qualifyingAnswer":"yes","criticalForEligibility":true}],"uncertainMessage":"Some of your answers were Not sure, so we could not confidently determine your eligibility.","qualifyingMessage":"Based on your answers, you appear to fall within the class definition for this settlement.","nonQualifyingMessage":"Based on your answers, you do not appear to fall within the class definition for this settlement."},"claimCategories":[],"proceedings":null,"relatedSlugs":[],"group":{"slug":"opioid-class-action","title":"Opioid Class Action","summary":"Three proposed settlements with Purdue Canada, Valeant and Mylan in the national opioid class action, Gebien v. Apotex, brought on behalf of Canadians who were prescribed or consumed opioid products and allege opioid dependency or addiction. Each settling defendant denies the allegations and the class action continues against the remaining defendants.","membersIntro":null,"structure":"multi_settlement","members":[{"slug":"purdue-canada-opioids-2026","title":"Purdue Canada Settlement","classDefinition":"All persons in Canada, except Excluded Persons, who were prescribed or consumed any opioid Product, together with their heirs, and any member of the Family Law Class (relatives with standing under s. 61(1) of the Family Law Act or equivalent legislation). Excluded Persons include anyone prescribed only OxyContin or OxyNEO between January 1, 1996 and February 28, 2017 and no other Products, officers or directors of the defendants, and members of the class in the Bourassa Class Action.","status":"Claims not yet open","geographic":["Canada-wide"],"deadline":"","lastVerifiedAt":"2026-08-16","isSelf":false},{"slug":"valeant-opioid-settlement-2026","title":"Valeant and Bausch Health Settlement","classDefinition":"All persons in Canada (except Quebec) who were prescribed or consumed any opioid product (as defined in the Settlement Agreement), together with their heirs, and any member of the Family Law Class. The Family Law Class includes persons who, by reason of a relationship to a Class Member, have standing under section 61(1) of the Family Law Act or equivalent legislation.","status":"Claims not yet open","geographic":["Canada-wide (Except Quebec)"],"deadline":"","lastVerifiedAt":"2026-08-16","isSelf":true},{"slug":"national-opioids-mylan-2026","title":"Mylan Settlement","classDefinition":"All persons in Canada (except Quebec) who were prescribed or consumed any opioid Product, together with their heirs, and any member of the Family Law Class. The Family Law Class includes all persons in Canada who, by reason of a relationship to a Class Member, have standing under section 61(1) of Ontario's Family Law Act or equivalent legislation in another province or territory, or the common law.","status":"Claims not yet open","geographic":["Canada-wide (Except Quebec)"],"deadline":"","lastVerifiedAt":"2026-08-16","isSelf":false}]},"cardSummary":"If you or a family member took opioid medications in Canada (outside Quebec) since 1996, a proposed $600,000 settlement with Valeant may affect you. Claims have not opened yet.","proofRequired":"","claimTime":"","claimAmount":"","coverageStartDate":"1996-01-01","coverageEndDate":"","deadline":"","optOutDeadline":"2026-05-04","objectionDeadline":null,"approvalHearingDate":"2026-09-16","approvalHearingDates":[{"date":"2026-09-16","label":""}],"approvalPending":false,"seriousHarmEnabled":false,"formHelperEnabled":false,"dateAdded":"2026-08-16","lastUpdated":"2026-08-16","firstPublishedAt":"2026-08-16 04:58:57","claimsOpenedAt":null,"lastVerifiedAt":"2026-08-16","languages":["en","fr"]}}